CRNX

Crinetics Pharmaceuticals (CRNX)

Crinetics Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CRNX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/12	05 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/06/12	05 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/06/12	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/06/12	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/06/11	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/06/11	00 : 55	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/06/04	05 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/31	05 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/29	02 : 44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/22	21 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/15	07 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/11	05 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/11	01 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/10	05 : 38	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/10	05 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/09	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/05/09	05 : 19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/03/12	05 : 15	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/03/07	10 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/03/07	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/03/07	10 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/03/07	10 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/03/07	09 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/03/07	09 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/03/02	06 : 41	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/02/29	06 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/02/15	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/02/13	06 : 32	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/01/27	07 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc
2024/01/26	03 : 03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CRNX	Crinetics Pharmaceuticals Inc